Retraction
LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis
Paper Information
Record ID:
47423
Author(s):
Publication Date:
October 01, 2021
Retraction Date:
September 05, 2023
(2.2 years years ago)
Subjects:
Institutions:
- Department of Oncology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, 150040, People’s Republic of China
- Nursing Teaching and Research Department, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, 150040, People’s Republic of China
- Department of Medical Laboratory, First Clinical Medical College, Mudanjiang Medical University, Mudanjiang City, Heilongjiang Province, 157011, People’s Republic of China
- Pharmacy Laboratory, College of Pharmacy, Mudanjiang Medical University, Mudanjiang City, Heilongjiang Province, 157011, People’s Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations2
Post-Retraction(15.4%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
134
Days since retraction (latest)
LncRNA <i>HCG11</i> enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis
Yufen Xu, Xiaoli Tan, Qi Yang et al. (5 authors)
Expert Review of Anticancer Therapy
Published: Jan 2024
3 citations
3 citations
134 days after retraction
miRNAs from Inflamed Gingiva Link Gene Signaling to Increased MET Expression
Liang Zheng, Avneesh Chopra, January Weiner et al. (6 authors)
Journal of Dental Research
Open Access
Published: Oct 2023
3 citations
3 citations
36 days after retraction
A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib et al. (10 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2023
17 citations
17 citations
1 days before retraction
LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
Weixi Chen, Zekun Bai, Wen Bai et al. (9 authors)
Scientific Reports
Open Access
Published: May 2023
4 citations
4 citations
119 days before retraction
Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu et al. (8 authors)
Oncology Reports
Open Access
Published: Feb 2023
4 citations
4 citations
204 days before retraction
IGF2BP2-modified UBE2D1 interacts with Smad2/3 to promote the progression of breast cancer.
Xiao-Qing Guan, Xiaoning Yuan, Kaixiang Feng et al. (14 authors)
PubMed
Published: Jan 2023
7 citations
7 citations
247 days before retraction
LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
Weixi Chen, Zekun Bai, Wen Bai et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Dec 2022
250 days before retraction
LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
Weixi Chen, Zekun Bai, Wen Bai et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Oct 2022
1 citation
1 citation
337 days before retraction
Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer
Xuemei Zeng, Juan Xiao, Xue Bai et al. (8 authors)
Pathology - Research and Practice
Published: Jul 2022
34 citations
34 citations
413 days before retraction
LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
Aini Shataer, Shayiti Bolati, Wei Ding et al. (8 authors)
Bioengineered
Open Access
Published: May 2022
14 citations
14 citations
491 days before retraction
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
Pía Loren, Nicolás Saavedra, Kathleen Saavedra et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: Apr 2022
13 citations
13 citations
519 days before retraction
Endoplasmic Reticulum Stress-Related Four-Biomarker Risk Classifier for Survival Evaluation in Esophageal Cancer
Xiang Xu, Yeqing Tang, Jiashan Zhu et al. (4 authors)
Journal of Oncology
Open Access
Published: Mar 2022
7 citations
7 citations
536 days before retraction
Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
Ying Liu, Xiang Ao, Yu Wang et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Jan 2022
68 citations
68 citations
585 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025